
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Concern about fever can lead parents—and health-care providers—to overmonitor and overtreat this common symptom. Accurate advice to parents begins with a clear understanding of fever on your part.






